PFE vs MRK: Stock Comparison

Pfizer, Inc. (PFE) and Merck & Company, Inc. Common Stock (new) (MRK) compared side by side on 20 fundamental metrics — valuation, profitability, growth, balance sheet, and returns. Live data, updated hourly.

PFE trades at the lower earnings multiple (37.88x vs 118.05x), while MRK has the higher return on equity (6.60% vs 4.89%).

Metric PFE MRK
Stock Price $30.03 $145.27
Market Cap $171.2B $358.4B
P/E Ratio 37.88 118.05
P/B Ratio 1.92 8.77
P/S Ratio 2.57 5.53
EV/EBITDA 17.87 29.93
PEG Ratio -0.63 -1.46
Return on Equity 4.89% 6.60%
ROCE 9.48% 10.83%
Return on Assets 2.16% 2.44%
Gross Margin 71.32% 75.38%
Net Margin 6.81% 4.78%
Revenue Growth (1y) -1.65% +1.18%
Profit Growth (1y) -3.12% +6.64%
Debt / Equity 0.74 1.29
Current Ratio 1.27 1.32
Interest Coverage 5.92 8.75
Dividend Yield 6.00% 2.29%
Beta 0.3 0.23
1-Year Return +30.26% +71.53%

Green bold marks the higher value on each metric, or the lower value for valuation multiples and debt-to-equity. It shows direction only and is not a ranking of either stock: sector norms, one-off items and growth stage all affect how a number reads. Not investment advice.

Full PFE data →  ·  Full MRK data →  ·  Screen 4,900+ stocks →

More Comparisons

All 60 stock comparisons →